InvestorsHub Logo
icon url

kommisar7

06/28/18 2:11 AM

#37380 RE: The Rainmaker #37378

I also have no concrete numbers ...
but i know that here international money is earned in the future and
so a Mc of $ 300 million is absolutely justified ...
$ 0.5 pps will come here ...
when...?
maybe next year or maybe in 2 years ....
or maybe this year ....
It will happen ....
icon url

JBizzle703

06/28/18 2:17 AM

#37381 RE: The Rainmaker #37378

Potenial Revenue...

The number that has been identified by multiple people is $1600 per kit is what each clinic has to pay to CMTH. I believe the cost to CMTH is $400 per kit, so that is $1200 in profit. $1200 in profit x 90000 men per year is $108M per year. That seems very optimistic(but is feasible with certain catalysts). There are a few things that this scenario doesn't take into account though:

1. International clients/clinics, which is obviously a focus given the new subsidiary and domain names being registered and documented interaction with foreign urologists at the AUA.
2.The treatment isn't limited in scope to just those who are resistant to PDE5 inhibitors, meaning the potential client base is bigger than the original 30% that the narrative was based off of.
3. Additional revenue from selling of the Magellan device to clinics

The potential numbers can get quite interesting once you factor those things in and then realize this is only the first of their commercialized treatments!